Stock Scorecard



Stock Summary for Lilly(Eli) & Company (LLY) - $746.06 as of 5/13/2025 8:46:32 PM EST

Total Score

11 out of 30

Safety Score

65 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for LLY

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for LLY

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for LLY

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for LLY

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for LLY (65 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 6
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for LLY

Why Weight-Loss Developer Stocks Tumbled on Tuesday 5/13/2025 11:08:00 PM
Trump's EO Targets Big Pharma Stocks like Eli Lilly 5/13/2025 8:36:00 PM
PFE vs. LLY: Which Stock Is the Better Value Option? 5/13/2025 3:40:00 PM
The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen 5/13/2025 1:22:00 PM
Why Lilly ( LLY ) International Revenue Trends Deserve Your Attention 5/13/2025 1:16:00 PM
RHHBY to Invest $1.25B to Boost Manufacturing Footprint in US 5/13/2025 12:21:00 PM
Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared 5/13/2025 11:36:00 AM
Pharma ETFs in Focus on Trump's Drug Price Overhaul 5/12/2025 2:30:00 PM
Pharma Stocks Hit by Trump's Vow to Cut US Prescription Drug Costs 5/12/2025 1:37:00 PM
Mark Cuban Challenges Charlie Kirk's Take On Big Pharma, Highlights Role Of PBMs In Drug Price Surge: 'For Your Company…Ask Your PBM For A List Of Claims' - Johnson & Johnson ( NYSE:JNJ ) , Eli Lilly ( NYSE:LLY ) 5/12/2025 11:40:00 AM

Financial Details for LLY

Company Overview

Ticker LLY
Company Name Lilly(Eli) & Company
Country USA
Description Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 3/31/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 746.06
Price 4 Years Ago 267.65
Last Day Price Updated 5/13/2025 8:46:32 PM EST
Last Day Volume 4,422,695
Average Daily Volume 4,618,200
52-Week High 969.25
52-Week Low 677.09
Last Price to 52 Week Low 10.19%

Valuation Measures

Trailing PE 61.58
Industry PE 29.04
Sector PE 49.22
5-Year Average PE 75.59
Free Cash Flow Ratio 216.25
Industry Free Cash Flow Ratio 19.04
Sector Free Cash Flow Ratio 31.82
Current Ratio Most Recent Quarter 1.37
Total Cash Per Share 3.45
Book Value Per Share Most Recent Quarter 16.64
Price to Book Ratio 44.23
Industry Price to Book Ratio 38.21
Sector Price to Book Ratio 30.58
Price to Sales Ratio Twelve Trailing Months 13.84
Industry Price to Sales Ratio Twelve Trailing Months 93.50
Sector Price to Sales Ratio Twelve Trailing Months 25.54
Analyst Buy Ratings 16
Analyst Strong Buy Ratings 7

Share Statistics

Total Shares Outstanding 897,736,000
Market Capitalization 669,764,920,160
Institutional Ownership N/A

Dividends

Ex-Dividend Date 5/16/2025
Previous Dividend Amount 1.5000
Current Dividend Amount 1.5000
Total Years Dividend Increasing Dividend Contender - Increasing for 10 Years
Trailing Annual Dividend Rate 5.40
Trailing Annual Dividend Yield 0.74%
Forward Annual Dividend Rate 6.00
Forward Annual Dividend Yield 0.82%
5-Year Dividend Payments Count 21
3-Year Average Dividend Yield 0.67%
5-Year Average Dividend Yield 0.95%
1-Year Dividend Growth Rate Percentage 15.38%
3-Year Dividend Growth Rate Percentage 7.42%
5-Year Dividend Growth Rate Percentage 15.26%
All-Time Dividend Growth Rate Percentage 8.61%
Dividend Payout Ratio 44.01%

Income Statement

Quarterly Earnings Growth YOY 23.40%
Annual Earnings Growth 102.08%
Reported EPS 12 Trailing Months 12.27
Reported EPS Past Year 3.34
Reported EPS Prior Year 13.00
Net Income Twelve Trailing Months 11,106,400,000
Net Income Past Year 10,590,000,000
Net Income Prior Year 5,240,400,000
Quarterly Revenue Growth YOY 45.20%
5-Year Revenue Growth 15.08%
Operating Margin Twelve Trailing Months 42.50%

Balance Sheet

Total Cash Most Recent Quarter 3,093,300,000
Total Cash Past Year 3,268,400,000
Total Cash Prior Year 2,818,600,000
Net Cash Position Most Recent Quarter -31,406,200,000
Net Cash Position Past Year -25,258,700,000
Long Term Debt Past Year 28,527,100,000
Long Term Debt Prior Year 18,320,800,000
Total Debt Most Recent Quarter 34,499,500,000
Equity to Debt Ratio Past Year 0.33
Equity to Debt Ratio Most Recent Quarter 0.31
Total Stockholder Equity Past Year 14,192,100,000
Total Stockholder Equity Prior Year 10,771,900,000
Total Stockholder Equity Most Recent Quarter 15,764,800,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 2,961,000,000
Free Cash Flow Per Share Twelve Trailing Months 3.30
Free Cash Flow Past Year 414,300,000
Free Cash Flow Prior Year -3,152,000,000

Options

Put/Call Ratio 0.54
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -11.64
MACD Signal 0.02
20-Day Bollinger Lower Band 702.18
20-Day Bollinger Middle Band 813.23
20-Day Bollinger Upper Band 924.27
Beta 0.47
RSI 34.88
50-Day SMA 842.19
150-Day SMA 602.11
200-Day SMA 515.88

System

Modified 5/13/2025 4:20:03 AM EST